secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0000950170-23-007459
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myomo Q4 revenue flat at $4.0M; net loss improves to $0.29/share
----------------------------------------------------------------

- Q4 product revenue $4.0M, flat YoY and up 2% sequentially; 101 units (down 6% YoY).
- Net loss attributable to common stockholders $2.2M ($0.29/share) vs $3.4M ($0.52) prior year.
- Gross margin 65.0% (down from 77.4% YoY) due to inflationary costs; operating expenses down 17%.
- Patient pipeline added 387 new candidates (+75% YoY); cost per pipeline add down 45% to $2,665.
- Jan 2023 workforce cut 12% to save ~$2.0M; guided Q1 product revenue +15-20% YoY, FY +20-30%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000095017023007459/0000950170-23-007459-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000095017023007459/myo-20230313.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-007459

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer